News & Events
2021
Kyowa Hakko Announces the Results of Three New Consumer Surveys on Consumer Preferences
December 15, 2021PRWeb.comNew consumer surveys reveal supplement users prefer branded ingredients 2x over generic ingredients when making purchasing decisions. Read more »
Kyowa Hakko USA Awarded Best-In-Class Ingredient by Natural Products Insider's Ingredient Idol for its Immune Support Postbiotic, IMMUSE™
November 16, 2021New York, NYHighlighted at the Annual Supply Side West Conference, the Function of Kyowa Hakko’s Novel Postbiotic was recognized as a leader for Immune Health. Read more »
iMUSE Wins 2021 Product of the Year Award in the Immune Support Category at the Nutralngredients-Asia Awards
September 30, 2021Tokyo, JapanKirin Holdings Company, Limited's (Kirin Holdings) iMUSE brand (IMMUSE™ in some markets), won the 2021 Product of the Year Award in the Immune Support category of the Nutralngredients-Asia Awards, held by William Reed Business Media (WRBM), a leading publisher of digital newsletters, publications and data sources for the food, beverage and nutrition industries worldwide. Read more »
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
September 21, 2021Santa Clara, CAThe solution offers superior ease of formulation, potential application versatility, and more comprehensive immune support compared to probiotics and other immune health ingredients. Read more »
Kirin Holdings to Double Lactococcus Lactis Strain Plasma Production
September 9, 2021Tokyo, JapanKirin Holdings Company, Limited (Kirin Holdings) announces that it will expand manufacturing equipment at the iMUSE Health Science Factory (located in Saitama Prefecture, just north of Tokyo) - a manufacturing center for lactic acid bacteria raw material - in order to meet the increasing demand for Kirin's proprietary Lactococcus lactis strain Plasma (L. lactis strain Plasma), the functional ingredient in the popular iMUSE brand of immune maintenance products. The new manufacturing equipment is scheduled to begin operating in 2023, and will double the annual production capacity of L. lactis strain Plasma to approximately 28 tons in 2023. Read more »
Performance Lab Unveils a Breakthrough Immunity Support Supplement, Featuring Two Kyowa Hakko Branded Ingredients
July 13, 2021New York, NYPerformance Lab Ultramodern Nutrition® has debuted a groundbreaking first-to-market immune support supplement available in the US, UK, EU, AUS, and Canada. PL-Immune™ features international health-ingredient manufacturer Kyowa Hakko’s Setria® Glutathione and IMMUSE™, dedicated to supporting immune health. Performance Lab® unites vision with technology to produce pure, potent, and effective finished supplements. Read more »
New Research Suggests Kyowa Hakko Bio’s Cognizin® Citicoline Aids in Memory Function
July 2, 2021New York, NYFindings published in The Journal of Nutrition demonstrate supplementation of citicoline for improved overall memory performance in healthy elderly populations. Read more »
New Research Highlighted at the International Society of Sports Nutrition Supports the Function of a Novel Kyowa Hakko Paraprobiotic for High-Intensity Training
June 30, 2021New York, NYKyowa Hakko showcased the latest branded ingredient innovations including IMMUSE™ Lactococcus lactis strain Plasma and EYEMUSE™ Lacticaseibacillus paracasei KW3110. Read more »
Launch of the IMMUSE® brand of plasma lactic acid bacteria in Europe
June 1, 2021Tokyo, JapanKirin Holdings Company, Limited (Kirin Holdings) announces the expansion of supply of Lactococcus lactis strain Plasma, the immune system functional ingredient, in Europe through the Kyowa Hakko Europe GmbH (Kyowa Hakko Europe), a distributor of Kyowa Hakko Bio Co., Ltd (Kyowa Hakko Bio). Read more »
Kyowa Hakko Launches Clinically-Researched Paraprobiotic for Eye Health
April 15, 2021The EyeMuse-branded ingredient is supported by published studies, giving formulators a new option for products for consumers with digital device-related eye fatigue, from everyday professionals to gamers. Read more »
Kyowa Hakko Announces Scientific-Breakthrough for Eye Health - EYEMUSE™ Enters the U.S. Market
April 6, 2021New York, NYKyowa Hakko, global leaders in the research, manufacturing and purification of high-quality health ingredients, is thrilled to introduce a new perspective on eye health. Its breakthrough clinically-researched eye health ingredient, EYEMUSE™, is entering the U.S. market, becoming the first heat-treated probiotic strain for healthy eye function, discovered by Kyowa Hakko’s parent-company Kirin Holdings Co., Ltd. Read more »
Kyowa Hakko Launches Setria® Glutathione "Breathe" Campaign
February 18, 2021Kyowa Hakko, global leaders in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products, is introducing its new “Breathe” brand campaign featuring Setria® Glutathione, a patented glutathione ingredient that supports respiratory and immune health*. Read more »
Get the "Love Bug" – Ladybug Potions® Launches I Love My Self Supplement Featuring Setria® Glutathione
February 10, 2021Founded by cousins Cilia Fishman and Laura Khoudari, Ladybug Potions® is entering the market with its cutting-edge dietary supplement, I Love Myself, focused on making self-care a top priority for its consumers. In doing so, the dynamic duo chose to include Kyowa Hakko’s clinically-studied Setria® Glutathione ingredient as a key part of the “potion’s” formula. Read more »
Copyright © 1998 – 2023 by KYOWA HAKKO U.S.A., INC. All Rights Reserved. | AWS
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.